Board of Directors

The OAC’s Board of Directors is composed of member cardiologists who are nominated by their peers in the profession to serve a one, two or three-year term. Elections for open positions on the Board are held yearly. OAC’s Board Members are leaders in the profession and serve as advocates for patients. The President receives guidance from the Board and OAC members and acts as the spokesperson for the Association on provincial cardiology and health care matters.


Jim Swan

President, Scarborough

Dr. Swan is lecturer in the Faculty of Medicine at the University of Toronto who practices clinical cardiology in Scarborough and was a founding member of CCN. He was involved with the development of the Standards for the Provision of Echocardiography Services in Ontario document and is committed to the implementation of this voluntary process. He has been involved with implementation of contrast echo in the province of Ontario and is a former member of the central tariff committee of the OMA.



Robert Wald

Secretary/Treasurer, Toronto

Dr. Robert W. Wald has been on the active staff of the Mount Sinai Hospital since 1978 and has a busy clinical practice in Cardiology at the Mount Sinai Hospital and at a community-based Satellite Clinic which he founded in 1995. He is Director of the Pacemaker Program, which he initiated at the Mount Sinai Hospital in 1984 and has been Deputy Physician-in-Chief since 1995.

Dr. Wald graduated from the University of Toronto in 1972 and completed his post-graduate training in Cardiology at the Toronto General Hospital, with a clinical and research interest in Cardiac Electrophysiology. He is an Associate Professor in the Department of Medicine at the University of Toronto and has over 50 peer-reviewed publications.

Dr. Wald has served on the Diagnostic Services Committee and numerous OMA/MOH working groups, the most recent being the Working Group on the Standards for the Provision of Echocardiography in Ontario.



Richard Davies

Board Member, Ottawa

Dr. Richard Davies is Professor in the Division of Cardiology at the University of Ottawa Heart Institute and Professor in the Department of Medicine at the University of Ottawa. Dr. Davies obtained his PhD in Physiological Psychology from McGill in 1976 and his MDCM from McGill in 1980. He subsequently trained in Internal Medicine at University of Toronto, Cardiology at the University of Ottawa and in Clinical Pharmacology at Vanderbilt University. He became a Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC) in 1984, and of the American College of Cardiology in 1987, and has been a Cardiologist at the University of Ottawa Heart Institute since 1986.

Dr. Davies has taken part in many of the Landmark Trials that have shaped cardiovascular care in areas of Cardiac Arrhythmia treatment, cholesterol lowering therapy, revascularization and treatment of myocardial ischemia, the treatment of congestive heart failure, cardiac secondary prevention and the treatment of cardiac patients with diabetes. He has served on CHIR and HSFA grant committees, and was co-Chair and Chair of the Heart and Stroke Foundation’s Clinical Research Committee.



John Parker

Board Member, Toronto

John D. Parker, MD received his medical degree from Queen’s University in Kingston Ontario in 1984. Following three years of training in internal medicine at Queens, he went to the Brigham and Woman’s Hospital in Boston where he completed five years of clinical and research training in cardiovascular medicine. He returned to Toronto in 1992 to take up his first faculty position as Assistant Professor of Medicine at the University of Toronto.

At the present time, he holds the rank of Professor of Medicine and Pharmacology at the University of Toronto. Dr. Parker is a clinician scientist at the Mount Sinai and University Health Network Hospital. He has a major interest in clinical research with a focus on clinical pharmacology and autonomic physiology in heart failure. These clinical research activities are supported by an active clinical program involving patient care. Dr. Parker is active as an invasive cardiologist and participates in a large clinical program involving the assessment and management of patients with advanced chronic congestive heart failure.



Michael Hartleib

Board Member, Peterborough

Dr. Michael Hartleib is a Staff Cardiologist at the Kawartha Cardiology Clinic in Peterborough, Ontario. He is a board certified Cardiologist with a fellowship from the Royal College of Physicians and Surgeons of Canada for both Adult Cardiology and Adult Critical Care Medicine. He completed his medical training at the University of Toronto including time as the Chief Cardiology Resident at Sunnybrook and Women’s College of Health Sciences Centre.

Dr. Hartleib is the President and leading Investigator of Kawartha Cardiology Clinical Trials. The clinical research team conduct clinical trials for cardiovascular disease, atherosclerosis, and many other conditions affecting the heart.

He is also actively involved at the Peterborough Regional Health Centre as the Cardiology Section Lead, Staff Intensivist and Cardiologist.

Dr. Hartleib lectures at Queen’s University as an Assistant Professor.



Joel Niznick

Board Member, Ottawa

Dr. Joel Niznick has been in practice since early July of 1986 attending at the Riverside Hospital and served as Director of the ICU for the hospital’s last eight years.

Dr. Niznick has active hospital privileges at the Ottawa Hospital General & Riverside Sites and is Managing Partner of the Ottawa Cardiovascular Centre. He has Associate Staff privileges at the Ottawa Heart Institute for cardiac catheterization.

Dr. Niznick’s main areas of clinical interest include cardiovascular risk reduction and clinical evidence dissemination and implementation. He has designed and developed the Continuing Medical Implementation website which is a premier knowledge translation site for cardiovascular disease management.



A.S. (Shekhar) Pandey

Board Member, Cambridge

Dr. A. Shekhar Pandey is an Assistant Clinical Professor (Adjunct) in the Department of Medicine at McMaster University. He is presently a Staff Cardiologist at Cambridge Memorial Hospital and is a Cathing Cardiologist at St. Mary’s Hospital in Kitchener, ON. He is the father of 3 boys who are the true joy & passion of his life. Growing up in Cape Breton, NS, he went on to complete his BSc at Dalhousie University and MD at the University of Toronto. He currently has appointments with the Ontario Drug Benefit Formulary and the Waterloo-Wellington Regional Cardiac Care Committee. He is the founder of the “Prevent” Clinic, a multi-disciplinary, high risk prevention clinic focused on risk modification and lifestyle optimization.

Included among his numerous awards and scholarships is the Rhodes Fellowship for Young Investigators with the International Society of Heart Research. Since 1987 he has authored over 30 publications and abstracts in such diverse areas as organic mercury toxicity, endothelin blockade, Congestive Heart Failure & Hyperlipidemia management.


 


Rakesh Bhargava

Board Member, Oshawa

Dr. Bhargava is Director of the Heart Care Cardiac Prevention and Rehabilitation Program of the Cardiac Wellness Centre, Oshawa and a staff cardiologist at Lakeridge Health, Oshawa. He was the Physician Leader, Critical care and Cardio Pulmonary program at Lakeridge Health, Oshawa. (1997 – 2000). He is an Assessor in the cardiology peer assessment program of the College of Physicians and Surgeons of Ontario since 1993. He is actively involved Cardiac research and was GTACC Research Chair in 2002–2003 and is presently the Chair of GTACC (Greater Toronto Area Community Cardiovascular Specialists organization).

He was the recipient of the Annual Award for Outstanding Innovation in Patient Care presented by the Research Institute in honour of the Auxiliary of Lakeridge Health Oshawa 2004.



Anatoly Langer

Board Member, Toronto

Dr. Anatoly Langer is a Professor of Medicine at the University of Toronto and chair of the Canadian Heart Research Centre, which he founded in 1996, in Toronto. Dr. Langer is also the chair of the Foundation for Medical Education and Research in Baltimore.

Dr. Langer has extensive research experience in the conduct of clinical trials with over 20 years of experience in protocol design, study coordination and data management. His areas of interest and research include pathophysiology and management of acute and stable coronary syndromes as well as treatment and prevention of cardiovascular disease.

Dr. Langer has over 250 peer reviewed publications, abstracts, and book chapters.



Mark Osten

Board Member, Toronto

Dr. Osten attended medical school at McMaster University (Hamilton, Canada). He completed cardiology fellowship at the University of Toronto (Toronto, Canada). He did additional training in interventional cardiology and adult congenital heart disease (Toronto, Canada). He is a staff cardiologist at the University of Toronto (Toronto, Canada). His areas of expertise include interventional cardiology, structural interventional cardiology and adult congenital heart disease.